Abstract
Outcome of 583 Entry Double-Blind Placebo-Controlled Peanut Challenges during Screening for the Palisade Phase 3 Oral Immunotherapy Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have